
|Videos|September 22, 2017
What Makes ABSSSI Antibiotic Iclaprim Unique?
Author(s)Contagion® Editorial Staff
William D. O’Riordan, MD, FACEP, explains what makes iclaprim a unique antibiotic.
Advertisement
William D. O’Riordan, MD, FACEP, chief medical officer, eStudySite, explains how iclaprim has a unique mechanism of action, making it a unique antibiotic to treat acute bacterial skin and skin structure infections. Dr. O’Riordan explains how dihydrofolate reductase interferes with an enzyme that is involved with the bacterial cell and essentially “does away” with it.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
2
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
3
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
4
Emerging Diagnostic Tools and Mycobacterial Challenges in Skin and Soft Tissue Infections
5